1. Construction of a Vero Cell Line Expressing Human ICAM1 for the Development of Rhinovirus Vaccines.
- Author
-
van den Braak, Wouter Johannes Petrus, Monica, Bella, Limpens, Diana, Rockx-Brouwer, Dedeke, de Boer, Matthijn, and Oosterhoff, Dinja
- Subjects
RHINOVIRUSES ,CELL adhesion molecules ,ENTEROVIRUSES ,VACCINE development ,CELL lines ,CD54 antigen ,COMMON cold - Abstract
Human rhinoviruses (HRVs) are small non-enveloped RNA viruses that belong to the Enterovirus genus within the Picornaviridae family and are known for causing the common cold. Though symptoms are generally mild in healthy individuals, the economic burden associated with HRV infection is significant. A vaccine could prevent disease. The Vero-cell-based viral vaccine platform technology was considered for such vaccine development. Unfortunately, most HRV strains are unable to propagate on Vero cells due to a lack of the major receptor of HRV group A and B, intercellular adhesion molecule (ICAM1, also known as CD54). Therefore, stable human ICAM1 expressing Vero cell clones were generated by transfecting the ICAM1 gene in Vero cells and selecting clones that overexpressed ICAM1 on the cell surface. Cell banks were made and expression of ICAM1 was stable for at least 30 passages. The Vero_ICAM1 cells and parental Vero cells were infected with four HRV prototypes, B14, A16, B37 and A57. Replication of all four viruses was detected in Vero_ICAM1, but not in the parental Vero cells. Altogether, Vero cells expressing ICAM1 could efficiently propagate the tested HRV strains. Therefore, ICAM1-expressing cells could be a useful tool for the development and future production of polyvalent HRV vaccines or other viruses that use ICAM1 as a receptor. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF